First Worldwide Internet Symposium on Drug-Induced QT Prolongation
ISHNE
Program
Date Session Speaker Topic



October 15th



Openning Lecture


Wojciech Zareba


Drug-Induce QT prolongation - talk
    Wojciech Zareba Drug-Induced QT prolongation - Manuscript
Mechanisms Charles Antzelevitch Drug-Induced Spatial Dispersion of Repolarization 
Methods Paul Kligfield ECG Measurement of QT Interval
Clinical Aspects Arthur Moss Long QT Syndrome as Paradigm for Drug-Induced QT Prolongation
Drug Testing William Wheeler Drug-Induced Torsade de Pointes: Regulatory Evolution



October 16th



Mechanisms


Nabil El-Sherif


Mechanism of Drug-Induced TdP
  Methods Ilan Goldenberg How to Measure QT
Clinical Aspects James Daubert Managing the Safety of Drugs for Atrial Fibrillation
Drug Testing Fabio Badilini QT Measurements On-screen Methods 



October 17th



Mechanisms


Dan Roden


Pharmacogenomics of Drug-Induced Conditions
  Methods Pentti Rautaharju Is QT Prolonged or Shortened? Normal Limits.
Clinical Aspects Wojciech Zareba Antipsychotic Drugs and Risk of TdP
Drug Testing Jean Philippe Couderc Beyond QT Prolongation in Drug Studies 



October 18th



Mechanisms


Michael Sanguinetti


hERG Channel Function in LQT2 and Drug Induced Conditions
  Methods Marek Malik Heart Rate Correction of the QT interval
Clinical Aspects Richard Kovacs Antibiotics and Acquired Long QT Syndrome: Advice for the Prescriber. 
Drug Testing Borje Darpo What QT prolongation is of concern?



October 19th



Mechanisms


Terry Campbell


Predicting Drug-HERG Interactions
  Methods Emanuela Locati QT Interval Dynamics
Clinical Aspects Luiz Belardinelli Not All QT-prolonging Drugs are Torsadogenics 
Drug Testing Dirhaj Narula ECG Core Laboratory Approach to Drug testing



October 20th



Mechanisms


Silvia Priori


Ion channel Genes and Propensity to TdP
  Methods Pierre Maison Blanche RR Bin Approach for QT analyses
Clinical Aspects Mark Haigney QT Variability and its Application for Drug Testing
Drug Testing William Wheeelr Assessing QT Liability in Oncology Drug Development



October 21th



Mechanisms


Michael Ackerman


Pharmacogenetics of Drug-Induced Sudden Cardiac Arrest
  Methods Antony Fossa ECG Restitution and its Relevance for Drug-Induced Repolarization Abnormalities
Clinical Aspects Ihor Gussak Short QT Interval and Drugs
Drug Testing Irina Salivieva Pacing in Drug Testing



October 22th



Clinical Aspects


Li Zhang


Case Demonstrations in Congenital and Acquired Long QT Syndrome. Can You Make A Correct ECG Interpretation?
  Methods Stefan Kaab Drug-induced LQT-Syndrome: Sotalol-Experience, Heart failure, Susceptibility to drug induced LQT
Methods Andrés Pérez Riera Relationship Among Amiodarone, New Class III Antiarrhytmics, Miscellaneous Agents and Acquired Long QT Syndrome



October 23th - 31th



Discussion
   
Grupo Akros